The cutting-edge of medicine; glucagon renaissance
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2013 |
---|---|
Erschienen: |
2013 |
Enthalten in: |
Zur Gesamtaufnahme - volume:102 |
---|---|
Enthalten in: |
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine - 102(2013), 12 vom: 10. Dez., Seite 3237-43 |
Sprache: |
Japanisch |
---|
Beteiligte Personen: |
Ishihara, Hisamitsu [VerfasserIn] |
---|
Themen: |
89750-14-1 |
---|
Anmerkungen: |
Date Completed 12.05.2014 Date Revised 24.07.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM236183567 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM236183567 | ||
003 | DE-627 | ||
005 | 20231224105026.0 | ||
007 | tu | ||
008 | 231224s2013 xx ||||| 00| ||jpn c | ||
028 | 5 | 2 | |a pubmed24n0787.xml |
035 | |a (DE-627)NLM236183567 | ||
035 | |a (NLM)24605576 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a jpn | ||
100 | 1 | |a Ishihara, Hisamitsu |e verfasserin |4 aut | |
245 | 1 | 4 | |a The cutting-edge of medicine; glucagon renaissance |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 12.05.2014 | ||
500 | |a Date Revised 24.07.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a Glucagon-Like Peptide 1 |2 NLM | |
650 | 7 | |a 89750-14-1 |2 NLM | |
650 | 7 | |a Glucagon |2 NLM | |
650 | 7 | |a 9007-92-5 |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine |d 1961 |g 102(2013), 12 vom: 10. Dez., Seite 3237-43 |w (DE-627)NLM000005851 |x 0021-5384 |7 nnns |
773 | 1 | 8 | |g volume:102 |g year:2013 |g number:12 |g day:10 |g month:12 |g pages:3237-43 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 102 |j 2013 |e 12 |b 10 |c 12 |h 3237-43 |